Decreased CD44v6 expression in lamina propria lymphocytes of patients with inflammatory bowel disease

Experimental and Molecular Pathology

Volumn 71, Issue 3, 2001, Pages 186-193

  Pfister, K ^a   Wittig, B M ^a   Mueller Molaian, I ^b   Remberger, K ^b   Zeitz, M ^a   Stallmach, A ^a  

^a Department of Internal Medicine II ^*  (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

CD44 variant isoforms; CD44v6; Inflammatory bowel disease; Lamina propria lymphocytes; T cell costimulation

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CD44V 6 ANTIGEN; CD44V ANTIGEN; STEROID; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DOWN REGULATION; ENTERITIS; ENZYME ANALYSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LAMINA PROPRIA; LYMPHOCYTE; PATHOGENESIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; ULCERATIVE COLITIS;

EID: 0035680630     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1006/exmp.2001.2404     Document Type: Article

References (44)

1. Participation in normal immune responses of a metastasis-inducing splice variant CD44
2. Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis
3. Phenotypes of T cells in the gut
4. CD4+ T lymphocytes injected into severe combined immunodeficient (SCID) mice lead to inflammatory and lethal bowel disease
5. Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40 activated naive human B cells to secret immunoglobulin A
6. Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes
7. Costimulation of the CD3 pathway by CD28 ligation in human intestinal lymphocytes
8. Inflammatory bowel disease: Etiology and pathogenesis
9. Disparate CD4+ lamina propria lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, Whereas ulcerative colitis LP cells manifest increased secretion of IL-5
10. Selective expansion of specific T cell receptors in the inflamed colon of Crohn's disease
11. CD44 in malignant disorders
12. Identification of a costimulatorv molecule rapidly induced by CD40L as CD44H
13. Functions of sphingolipids and sphongotipid breakdown products in cellular regulation
14. Changes in CD44 isoform expression during inflammatory skin disease
15. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody
16. The phenotype and function of T cells in the lamina propria of the human intestine
17. Serum levels of soluble CD44 variant isoforms are elevated in rheumatoid arthritis
18. Coupling of signal transduction to alternative pre-mRNA splicing by a composite splice regulator
19. CD44 splice variant: Expression on lymphocytes and in neoplasia
20. Sequential expression of genes involved in human T lymphocyte growth and differentiation
21. Inflammatory bowel disease in C.B-17 scid mice reconstituted with CD45RBhigh subset of CD4+ T cells
22. Expression and modulation of CD44 variant isoforms in humans
23. An alternative pathway of T cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor protein
24. Activation of peripheral blood and intestinal lymphocytes in Crohn's disease: In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens
25. Persistent clonal expansions of peripheral blood CD4+ lymphocytes in chronic inflammatory bowel disease
26. Down-regulated of protein kinase C activation in human lamina propria T lymphocytes: Influence of intestinal mucosa on T cell reactivity
27. Alterations of the phenotype of colonic macrophages in inflammatory bowel disease
28. Differential distribution of B7.1 (CD80) and B7.2 (CD86) costimulatory molecules on mucosal macrophage subsets in human inflammatory bowel disease (IBD)
29. Loss of CD4+ T lymphocytes in patients with human immunodeficienty virus type 1 is more pronounced in the doudenal mucosa than in the peripheral blood
30. Increased activation of isolated intestinal lamina propria mononuctear cells in inflammatory bowel disease
31. CD44 variant isoform expression in a variety of skin associated autoimmune diseases
32. The CD44 variant isoforms CD44v6 and CD44v7 are expressed by distinct leukocyte subpopulations and exert non-overlapping functional activities
33. Down-regulation of specific binding of (20-3H)phorbol 12,13-dibutyrat and phorbol ester-induced differenciation of human promyeloic leukemia cells
34. Increased state of activation of CD4-positive T cells and elevated interferon-g production in pouchitis
35. CD44 isoforms: Impact on lymphocyte activation and differentiation
36. The pathogenesis of mucosal inflammation in murine models of inflammatory bowel disease and Crohn's disease
37. Definition of a lamina propria T cell responsive state. Enhanced cytokine responsiveness of T cells stimulated through the CD2 pathway
38. Cortisone in ulcerative colitis. Final report on a therapeutical trial
39. Selective upregulation of CD44 variant isoforms on peripheral blood leukocytes in patients with chronic inflammatory bowel disease and other systemic autoimmune disease
40. Pathogenesis of inflammatory bowel disease
41. Lymphocytes isolated from the intestinal lamina propria of normal non-human primates have increased expression of genes associated with T cell activation
42. Mucosal T cells provide helper function but do not proliferate when stimulated by specific antigen in lymphogranuloma venerum proctitis in non-human primates
43. Phenotype and function of lamina propria T cells
44. CD44: Physiological expression of distinct isoforms as evidence for organ-specific formation